Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 -- Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system ...

Related Keywords

Boston ,Massachusetts ,United States , ,Facebook ,Nasdaq ,Compensation Committee Of Praxi Board Directors ,Praxis Precision Medicines Inc ,Globenewswire Inc ,Linkedin ,Precision Medicines ,Compensation Committee ,Praxi Board ,Nasdaq Listing Rule ,Nasdaq Global Select Market ,Investor Contact ,Science Advisors ,